z-logo
open-access-imgOpen Access
Clinical Significance of miR-210 and its Prospective Signaling Pathways in Non-Small Cell Lung Cancer: Evidence from Gene Expression Omnibus and the Cancer Genome Atlas Data Mining with 2763 Samples and Validation via Real-Time Quantitative PCR
Author(s) -
RongQuan He,
Weiluan Cen,
Jiemei Cen,
Wei-ning Cen,
Jiayi Li,
Meiwei Li,
TingQing Gan,
Xiaohua Hu,
Gang Chen
Publication year - 2018
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000488823
Subject(s) - lung cancer , microrna , clinical significance , non small cell lung cancer (nsclc) , meta analysis , gene expression , biomarker , oncology , gene , biology , cancer , cancer research , human protein atlas , survival analysis , gene expression profiling , medicine , bioinformatics , genetics , a549 cell , protein expression
Since the function of microRNA (miR)-210 in non-small cell lung cancer (NSCLC) remains unclear, we aimed to explore the clinical significance of miR-210 in NSCLC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom